Diabetes Drug Wins Approval, Helps the Competition

The approval of Novo Nordisk’s diabetes drug Victoza has led to an unintended benefit for a competitor.

Read more »

VIVUS’ Qnexa Shows Promise For Diabetics

VIVUS, a pharmaceutical company specializing in products to treat sexual function, announced that their experimental obesity drug Qnexa was shown to improve blood sugar control in patients with type 2 diabetes.

Read more »